selected publications Molecular and Functional Alterations in the Cerebral Microvasculature in an Optimized Mouse Model of Sepsis-Associated Cognitive Dysfunction. eNeuro. 2024 Academic Article GET IT Times cited: 4 Molecular and functional alterations in the cerebral microvasculature in an optimized mouse model of sepsis-associated cognitive dysfunction. 2024 GET IT Molecular and functional alterations in the cerebral microvasculature in an optimized mouse model of sepsis-associated cognitive dysfunction. bioRxiv. https://www.biorxiv.org/content/10.1101/2024.05.28.596050v1. 2024 Academic Article Molecular profiling of the stroke-induced alterations in the cerebral microvasculature reveals promising therapeutic candidates. Proceedings of the National Academy of Sciences of the United States of America. 2023 Academic Article GET IT Times cited: 14 Vascular oxidative stress causes neutrophil arrest in brain capillaries, leading to decreased cerebral blood flow and contributing to memory impairment in a mouse model of Alzheimer’s disease. 2023 GET IT Vascular oxidative stress causes neutrophil arrest in brain capillaries, leading to decreased cerebral blood flow and contributing to memory impairment in a mouse model of Alzheimer’s disease. https://doi.org/10.1101/2023.02.15.528710. BioRxiv. 2023 Academic Article Cellular stress signaling activates type-I IFN response through FOXO3-regulated lamin posttranslational modification. Nature communications. 2021 Academic Article GET IT Times cited: 35 Endothelial S1P1 Signaling Counteracts Infarct Expansion in Ischemic Stroke. Circulation research. 2020 Academic Article GET IT Times cited: 104 The isolation and molecular characterization of cerebral microvessels. Nature protocols. 2019 Academic Article GET IT Times cited: 84 Evaluation of S1PR1, pSTAT3, S1PR2, FOXP1 Expression in Aggressive, Mature B Cell Lymphomas. Journal of hematopathology. 2019 Academic Article GET IT Times cited: 6 An engineered S1P chaperone attenuates hypertension and ischemic injury. Science signaling. 2017 Academic Article GET IT Times cited: 92 Size-selective opening of the blood-brain barrier by targeting endothelial sphingosine 1-phosphate receptor 1. Proceedings of the National Academy of Sciences of the United States of America. 2017 Academic Article GET IT Times cited: 174 Sphingosine-1-Phosphate Signaling in Endothelial Disorders. Current atherosclerosis reports. 2016 Review GET IT Times cited: 23 Critical role of sphingosine-1-phosphate receptor-2 in the disruption of cerebrovascular integrity in experimental stroke. Nature communications. 2015 Academic Article GET IT Times cited: 130 Critical role of sphingosine-1-phosphate receptor 2 (S1PR2) in acute vascular inflammation. Blood. 2013 Academic Article GET IT Times cited: 154 Sphingosine-1-phosphate receptor 1 in classical Hodgkin lymphoma: assessment of expression and role in cell migration. Laboratory investigation; a journal of technical methods and pathology. 2013 Academic Article GET IT Times cited: 39 S1P/S1P2 signaling induces cyclooxygenase-2 expression in Wilms tumor. The Journal of urology. 2009 Academic Article GET IT Times cited: 26 S1P/S1P1 signaling stimulates cell migration and invasion in Wilms tumor. Cancer letters. 2009 Academic Article GET IT Times cited: 54 Induction of antiproliferative connective tissue growth factor expression in Wilms' tumor cells by sphingosine-1-phosphate receptor 2. Molecular cancer research : MCR. 2008 Academic Article GET IT Times cited: 60 Up-regulating sphingosine 1-phosphate receptor-2 signaling impairs chemotactic, wound-healing, and morphogenetic responses in senescent endothelial cells. The Journal of biological chemistry. 2008 Academic Article GET IT Times cited: 44 Essential role of sphingosine 1-phosphate receptor 2 in pathological angiogenesis of the mouse retina. The Journal of clinical investigation. 2007 Academic Article GET IT Times cited: 197 Induction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN. Arteriosclerosis, thrombosis, and vascular biology. 2007 Academic Article GET IT Times cited: 220 Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization. Cancer research. 2006 Academic Article GET IT Times cited: 237 GR 63799X, an EP3 receptor agonist, induced S phase arrest and 3T6 fibroblast growth inhibition. European journal of pharmacology. 2005 Academic Article GET IT Times cited: 11 PTEN as an effector in the signaling of antimigratory G protein-coupled receptor. Proceedings of the National Academy of Sciences of the United States of America. 2005 Academic Article GET IT Times cited: 137 Structural and functional characteristics of S1P receptors. Journal of cellular biochemistry. 2004 Review GET IT Times cited: 384 Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability. The Journal of biological chemistry. 2003 Academic Article GET IT Times cited: 341 Calcium-independent phospholipase A2 through arachidonic acid mobilization is involved in Caco-2 cell growth. Journal of cellular physiology. 2002 Academic Article GET IT Times cited: 37 Role of EP(1) and EP(4) PGE(2) subtype receptors in serum-induced 3T6 fibroblast cycle progression and proliferation. American journal of physiology. Cell physiology. 2002 Academic Article GET IT Times cited: 36 Role of phospholipases A(2) in growth-dependent changes in prostaglandin release from 3T6 fibroblasts. Journal of cellular physiology. 2001 Academic Article GET IT Times cited: 10 Olive oil decreases both oxidative stress and the production of arachidonic acid metabolites by the prostaglandin G/H synthase pathway in rat macrophages. The Journal of nutrition. 2001 Academic Article GET IT Times cited: 63 The effect of high molecular phospholipase A2 inhibitors on 3T6 fibroblast proliferation. Biochemical pharmacology. 2001 Academic Article GET IT Times cited: 24 Serum withdrawal-induced post-transcriptional stabilization of cyclooxygenase-2 mRNA in MDA-MB-231 mammary carcinoma cells requires the activity of the p38 stress-activated protein kinase. The Journal of biological chemistry. 2000 Academic Article GET IT Times cited: 69 Regulation of prostaglandin E2 production by the superoxide radical and nitric oxide in mouse peritoneal macrophages. Free radical research. 2000 Academic Article GET IT Times cited: 42 Role of leukocyte influx in tissue prostaglandin H synthase-2 overexpression induced by phorbol ester and arachidonic acid in skin. Biochemical pharmacology. 1999 Academic Article GET IT Times cited: 36 Role of prostaglandin H synthase isoforms in murine ear edema induced by phorbol ester application on skin. Prostaglandins & other lipid mediators. 1999 Academic Article GET IT Times cited: 27 Ketoprofen S(+) enantiomer inhibits prostaglandin production and cell growth in 3T6 fibroblast cultures. European journal of pharmacology. 1999 Academic Article GET IT Times cited: 18 Induction by interleukin-1beta peptide of prostaglandin E2 formation via enhanced prostaglandin H synthase-2 expression in 3T6 fibroblasts. Biochemical pharmacology. 1998 Academic Article GET IT Times cited: 4 Role of prostaglandin H synthase-2-mediated conversion of arachidonic acid in controlling 3T6 fibroblast growth. The American journal of physiology. 1997 Academic Article GET IT Times cited: 39
Funding awarded Unraveling Mechanisms and Novel Therapeutic Strategies in Cerebral Microvascular Dysfunction and Cognitive Impairment. Principal Investigator 2025 - 2030 Role and therapeutic targeting of the cerebral microvasculature in dementia awarded by Alzheimer''s Association National Office Principal Investigator 2025 - 2028 Biopharma Agreement with Sanofi S.A awarded by Sanofi S.A. Principal Investigator 2025 - 2026 Endothelial Sphingolipid Signaling in Neurovascular Ischemic Injury awarded by National Institute of Neurological Disorders & Stroke Principal Investigator 2020 - 2026 missing activity Principal Investigator 2022 - 2025 Stalled Capillary Flow: a Novel Mechanism for Hypoperfusion in Alzheimer's Disease Co-Principal Investigator
education and training Pharm.B., University of Barcelona (Spain) 96 Ph.D., University of Barcelona (Spain) 2001 M.S., University of Barcelona (Spain) 1997